{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:17:31Z","timestamp":1782775051377,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Canadian Institutes of Health Research Project Grant","award":["CIHR TT7 128272"],"award-info":[{"award-number":["CIHR TT7 128272"]}]},{"name":"Australian Government Research Training Program Scholarship"},{"name":"Australia Award-Endeavour Research Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10552-019-01203-0","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T11:02:12Z","timestamp":1562410932000},"page":"931-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Patterns of comorbidities in women with breast cancer: a Canadian population-based study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-5253","authenticated-orcid":false,"given":"Huah Shin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-6453","authenticated-orcid":false,"given":"Agnes","family":"Vitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-1642","authenticated-orcid":false,"given":"Bogda","family":"Koczwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-4409","authenticated-orcid":false,"given":"David","family":"Roder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-7420","authenticated-orcid":false,"given":"Mary L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,6]]},"reference":[{"key":"1203_CR1","unstructured":"Canadian Cancer Society. Breast cancer statistics. Canadian Cancer Society, 2017. \n                    http:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/breast\/statistics\/?region=bc\n                    \n                  . Accessed 18 June 2018"},{"key":"1203_CR2","unstructured":"Canadian Cancer Society\u2019s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2015. Canadian Cancer Society, 2015. \n                    http:\/\/www.cancer.ca\/~\/media\/cancer.ca\/CW\/cancer%20information\/cancer%20101\/Canadian%20cancer%20statistics\/Canadian-Cancer-Statistics-2015-EN.pdf?la=en\n                    \n                  . Accessed 9 Sept 2018"},{"key":"1203_CR3","first-page":"41","volume":"29","author":"AW Smith","year":"2008","unstructured":"Smith AW, Reeve BB, Bellizzi KM, Harlan LC, Klabunde CN et al (2008) Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev 29:41\u201356","journal-title":"Health Care Financ Rev"},{"key":"1203_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5694\/mja17.00006","volume":"208","author":"HS Ng","year":"2018","unstructured":"Ng HS, Koczwara B, Roder D, Niyonsenga T, Vitry A (2018) Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis. Med J Aust 208:24\u201328","journal-title":"Med J Aust"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.15256\/joc.2018.8.125","volume":"8","author":"HS Ng","year":"2018","unstructured":"Ng HS, Koczwara B, Roder D, Niyonsenga T, Vitry A (2018) Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study. J Comorb 8:16\u201324","journal-title":"J Comorb"},{"key":"1203_CR6","doi-asserted-by":"publisher","first-page":"E734","DOI":"10.9778\/cmajo.20170030","volume":"5","author":"S Fallahpour","year":"2017","unstructured":"Fallahpour S, Navaneelan T, De P, Borgo A (2017) Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open 5:E734\u2013E739","journal-title":"CMAJ Open"},{"key":"1203_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/dc17-2012","volume":"41","author":"IC Lega","year":"2018","unstructured":"Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK et al (2018) The impact of diabetes on breast cancer treatments and outcomes: a population-based study. Diabetes Care 41:755\u2013761","journal-title":"Diabetes Care"},{"key":"1203_CR8","unstructured":"Chronic Disease Prevention Alliance of Canada. 2018 pre-budget submission to the House of Commons Standing Committee on Finance. CDPAC, 2017. \n                    https:\/\/www.ourcommons.ca\/Content\/Committee\/421\/FINA\/Brief\/BR9073636\/br-external\/ChronicDiseasePreventionAllianceOfCanada-e.pdf\n                    \n                  . Accessed 19 Sept 2018"},{"key":"1203_CR9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.9778\/cmajo.20170144","volume":"6","author":"C de Oliveira","year":"2018","unstructured":"de Oliveira C, Weir S, Rangrej J, Krahn MD, Mittmann N et al (2018) The economic burden of cancer care in Canada: a population-based cost study. CMAJ Open 6:E1\u2013E10","journal-title":"CMAJ Open"},{"key":"1203_CR10","unstructured":"Madore O. The Canada Health Act: overview and option. Parliment of Canada, 2005. \n                    http:\/\/www.res.parl.gc.ca\/Content\/LOP\/ResearchPublications\/944-e.htm\n                    \n                  . Accessed 7 July 2018"},{"key":"1203_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.17269\/cjph.107.5244","volume":"107","author":"A Hinds","year":"2016","unstructured":"Hinds A, Lix LM, Smith M, Quan H, Sanmartin C (2016) Quality of administrative health databases in Canada: a scoping review. Can J Public Health 107:6","journal-title":"Can J Public Health"},{"key":"1203_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jclinepi.2012.02.017","volume":"65","author":"D Sarfati","year":"2012","unstructured":"Sarfati D (2012) Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol 65:924\u2013933","journal-title":"J Clin Epidemiol"},{"key":"1203_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/02841860701367878","volume":"46","author":"NM Aziz","year":"2007","unstructured":"Aziz NM (2007) Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 46:417\u2013432","journal-title":"Acta Oncol"},{"key":"1203_CR14","unstructured":"BC Cancer Agency Registry Data (2011). V2. Population Data BC [publisher]. Data Extract. BC Cancer Agency (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 15 Aug 2015"},{"key":"1203_CR15","unstructured":"British Columbia Ministry of Health [creator] (2011): Consolidation File (MSP Registration & Premium Billing). V2. Population Data BC [publisher]. Data Extract. MOH (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 9 Sept 2015"},{"key":"1203_CR16","unstructured":"British Columbia Ministry of Health [creator] (2011): Medical Services Plan (MSP) Payment Information File. V2. Population Data BC [publisher]. Data Extract. MOH (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 9 Sept 2015"},{"key":"1203_CR17","unstructured":"Canadian Institute for Health Information [creator] (2011): Discharge Abstract Database (Hospital Separations). V2. Population Data BC [publisher]. Data Extract. MOH (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 9 Sept 2015"},{"key":"1203_CR18","unstructured":"BC Ministry of Health [creator] (2011): PharmaNet. V2. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 22 Sept 2015"},{"key":"1203_CR19","unstructured":"BC Vital Statistics Agency [creator] (2011): Vital Statistics Deaths. V2. Population Data BC [publisher]. Data Extract BC Vital Statistics Agency (2011). \n                    http:\/\/www.popdata.bc.ca\/data\n                    \n                  . Accessed 9 Sept 2015"},{"key":"1203_CR20","unstructured":"Population Data BC. About PopData. PopData BC, 2016. \n                    https:\/\/www.popdata.bc.ca\/aboutus\n                    \n                  . Accessed 9 July 2018"},{"key":"1203_CR21","volume-title":"International classification of diseases for oncology (ICD-O)","author":"World Health Organization (WHO)","year":"2000","unstructured":"World Health Organization (WHO) (2000) International classification of diseases for oncology (ICD-O), 3rd edn. World Health Organization, Geneva","edition":"3"},{"key":"1203_CR22","first-page":"761","volume":"41","author":"KL Sloan","year":"2003","unstructured":"Sloan KL, Sales AE, Liu CF, Fishman P, Nichol P et al (2003) Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care 41:761\u2013774","journal-title":"Med Care"},{"key":"1203_CR23","unstructured":"Johns Hopkins Bloomberg School of Public Health (2016) The Johns Hopkins ACG System technical reference guide version 11.1"},{"key":"1203_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/MLR.0b013e318215d5e2","volume":"49","author":"PC Austin","year":"2011","unstructured":"Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM (2011) Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 49:932\u2013939","journal-title":"Med Care"},{"key":"1203_CR25","unstructured":"Public Health Agency of Canada. Preventing chronic disease strategic plan 2013-2016. Public Health Agency of Canada, 2013. \n                    https:\/\/www.iccp-portal.org\/system\/files\/plans\/HP35-39-2013-eng.pdf\n                    \n                  . Accessed 18 June 2018"},{"key":"1203_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.24095\/hpcdp.36.10.01","volume":"36","author":"C Steensma","year":"2016","unstructured":"Steensma C, Loukine L, Orpana H, McRae L, Vachon J et al (2016) Describing the population health burden of depression: health-adjusted life expectancy by depression status in Canada. Health Promot Chronic Dis Prev Can 36:205\u2013213","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"1203_CR27","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00198-012-1931-z","volume":"23","author":"JE Tarride","year":"2012","unstructured":"Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD et al (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int 23:2591\u20132600","journal-title":"Osteoporos Int"},{"key":"1203_CR28","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/bjc.2011.420","volume":"105","author":"NF Khan","year":"2011","unstructured":"Khan NF, Mant D, Carpenter L, Forman D, Rose PW (2011) Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer 105:S29\u2013S37","journal-title":"Br J Cancer"},{"key":"1203_CR29","doi-asserted-by":"publisher","first-page":"055","DOI":"10.1093\/jnci\/dju055","volume":"106","author":"N Howlader","year":"2014","unstructured":"Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA et al (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106:055","journal-title":"J Natl Cancer Inst"},{"key":"1203_CR30","unstructured":"Public Health Agency of Canada. Breast cancer. Government of Canada, 2017. \n                    https:\/\/www.canada.ca\/en\/public-health\/services\/chronic-diseases\/cancer\/breast-cancer.html\n                    \n                  . Accessed 14 Aug 2018"},{"key":"1203_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-014-3021-8","volume":"146","author":"JH Jordan","year":"2014","unstructured":"Jordan JH, Thwin SS, Lash TL, Buist DSM, Field TS et al (2014) Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat 146:401\u2013409","journal-title":"Breast Cancer Res Treat"},{"key":"1203_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/cir.0000000000000556","volume":"22","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V et al (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 22:22. \n                    https:\/\/doi.org\/10.1161\/cir.0000000000000556","journal-title":"Circulation"},{"key":"1203_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/clc.22886","volume":"41","author":"M Gulati","year":"2018","unstructured":"Gulati M, Mulvagh SL (2018) The connection between the breast and heart in a woman: breast cancer and cardiovascular disease. Clin Cardiol 41:253\u2013257","journal-title":"Clin Cardiol"},{"key":"1203_CR34","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674\u20131685","journal-title":"Diabetes Care"},{"key":"1203_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000365951","volume":"9","author":"D Hauner","year":"2014","unstructured":"Hauner D, Hauner H (2014) Metabolic syndrome and breast cancer: is there a link? Breast Care 9:277\u2013281","journal-title":"Breast Care"},{"key":"1203_CR36","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI et al (2009) Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"1203_CR37","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/GME.0b013e31828ce95d","volume":"20","author":"K Esposito","year":"2013","unstructured":"Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI et al (2013) Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 20:1301\u20131309","journal-title":"Menopause"},{"key":"1203_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1634\/theoncologist.2015-0424","volume":"21","author":"H-D Long","year":"2016","unstructured":"Long H-D, Lin Y-E, Zhang J-J, Zhong W-Z, Zheng R-N (2016) Risk of congestive heart failure in early breast cancer patients undergoing adjuvant treatment with trastuzumab: a meta-analysis. Oncologist 21:547\u2013554","journal-title":"Oncologist"},{"key":"1203_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","volume":"104","author":"EJA Bowles","year":"2012","unstructured":"Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN et al (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 104:1293\u20131305","journal-title":"J Natl Cancer Inst"},{"key":"1203_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40959-016-0011-5","volume":"2","author":"AF Yu","year":"2016","unstructured":"Yu AF, Jones LW (2016) Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures. Cardio-Oncology 2:1","journal-title":"Cardio-Oncology"},{"key":"1203_CR41","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1161\/jaha.1117.005633","volume":"6","author":"YJ Cheng","year":"2017","unstructured":"Cheng YJ, Nie XY, Ji CC, Lin XX, Liu LJ et al (2017) Long-term cardiovascular risk after radiotherapy in women with breast cancer. J Am Heart Assoc 6:5654. \n                    https:\/\/doi.org\/10.1161\/jaha.1117.005633","journal-title":"J Am Heart Assoc"},{"key":"1203_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.radonc.2011.06.016","volume":"100","author":"P McGale","year":"2011","unstructured":"McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson N-O et al (2011) Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100:167\u2013175","journal-title":"Radiother Oncol"},{"key":"1203_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2165\/00002018-200528050-00004","volume":"28","author":"JR Molina","year":"2005","unstructured":"Molina JR, Barton DL, Loprinzi CL (2005) Chemotherapy-induced ovarian failure. Drug Saf 28:401\u2013416","journal-title":"Drug Saf"},{"key":"1203_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(18)30047-0","author":"TD Rachner","year":"2018","unstructured":"Rachner TD, Coleman R, Hadji P, Hofbauer LC (2018) Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol. \n                    https:\/\/doi.org\/10.1016\/s2213-8587(18)30047-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1203_CR45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.berh.2009.09.003","volume":"23","author":"M Ghazi","year":"2009","unstructured":"Ghazi M, Roux C (2009) Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer. Best Pract Res Clin Rheumatol 23:805\u2013811","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1203_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-012-2793-9","volume":"56","author":"LL Lipscombe","year":"2013","unstructured":"Lipscombe LL, Chan WW, Yun L, Austin PC, Anderson GM et al (2013) Incidence of diabetes among postmenopausal breast cancer survivors. Diabetologia 56:476\u2013483","journal-title":"Diabetologia"},{"key":"1203_CR47","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jdiacomp.2016.12.010","volume":"31","author":"B Xu","year":"2017","unstructured":"Xu B, Lovre D, Mauvais-Jarvis F (2017) The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: basic and clinical insights. J Diabetes Complicat 31:773\u2013779","journal-title":"J Diabetes Complicat"},{"key":"1203_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.genhosppsych.2007.10.008","volume":"30","author":"JR Fann","year":"2008","unstructured":"Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M et al (2008) Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 30:112\u2013126","journal-title":"Gen Hosp Psychiatry"},{"key":"1203_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.annepidem.2016.04.004","volume":"26","author":"ML Santorelli","year":"2016","unstructured":"Santorelli ML, Hirshfield KM, Steinberg MB, Rhoads GG, Lin Y et al (2016) Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women. Ann Epidemiol 26:436\u2013440","journal-title":"Ann Epidemiol"},{"key":"1203_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1176\/appi.psy.48.3.205","volume":"48","author":"KC Lee","year":"2007","unstructured":"Lee KC, Thomas Ray G, Hunkeler EM, Finley PR (2007) Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 48:205\u2013210","journal-title":"Psychosomatics"},{"key":"1203_CR51","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/cncr.23307","volume":"112","author":"GL Smith","year":"2008","unstructured":"Smith GL, Smith BD, Giordano SH, Shih YCT, Woodward WA et al (2008) Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112:1371\u20131379","journal-title":"Cancer"},{"key":"1203_CR52","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ijrobp.2008.11.037","volume":"75","author":"KV Reinertsen","year":"2009","unstructured":"Reinertsen KV, Cvancarova M, Wist E, Bj\u00f8ro T, Dahl AA et al (2009) Thyroid Function in women after multimodal treatment for breast cancer stage II\/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys 75:764\u2013770","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1203_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.meddos.2017.03.003","volume":"42","author":"G Kanyilmaz","year":"2017","unstructured":"Kanyilmaz G, Aktan M, Koc M, Demir H, Demir LS (2017) Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases. Med Dosim 42:190\u2013196","journal-title":"Med Dosim"},{"key":"1203_CR54","first-page":"1713","volume":"30","author":"N Ditsch","year":"2010","unstructured":"Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M et al (2010) Thyroid function in breast cancer patients. Anticancer Res 30:1713\u20131717","journal-title":"Anticancer Res"},{"key":"1203_CR55","first-page":"e589","volume":"62","author":"L Jiang","year":"2016","unstructured":"Jiang L, Lofters A, Moineddin R, Decker K, Groome P et al (2016) Primary care physician use across the breast cancer care continuum\u2014CanIMPACT study using Canadian administrative data. Can Fam Physician 62:e589\u2013e598","journal-title":"Can Fam Physician"},{"key":"1203_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2296-13-60","volume":"13","author":"L Jabaaij","year":"2012","unstructured":"Jabaaij L, van den Akker M, Schellevis FG (2012) Excess of health care use in general practice and of comorbid chronic conditions in cancer patients compared to controls. BMC Fam Pract 13:60","journal-title":"BMC Fam Pract"},{"key":"1203_CR57","doi-asserted-by":"publisher","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E et al (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol 23:vii155\u2013vii166","journal-title":"Ann Oncol"},{"key":"1203_CR58","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ctrv.2008.03.007","volume":"34","author":"DM Reid","year":"2008","unstructured":"Reid DM, Doughty J, Eastell R, Heys SD, Howell A et al (2008) Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev 34:S3\u2013S18","journal-title":"Cancer Treat Rev"},{"key":"1203_CR59","unstructured":"Macmillan Cancer Support, National Cancer Intelligence Network (NCIN), Monitor Deloitte. Routes from Diagnosis: the most detailed map of cancer survivorship yet. Macmillan Cancer Support, United Kingdom, 2014. \n                    https:\/\/www.macmillan.org.uk\/_images\/Routesfromdiagnosisreport_tcm9-265651.pdf\n                    \n                  . Accessed 19 Dec 2017)"},{"key":"1203_CR60","first-page":"803","volume":"24","author":"M Fafouti","year":"2010","unstructured":"Fafouti M, Paparrigopoulos T, Zervas Y, Rabavilas A, Malamos N et al (2010) Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. Vivo 24:803\u2013810","journal-title":"Vivo"},{"key":"1203_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-007-9706-5","volume":"110","author":"M Reich","year":"2008","unstructured":"Reich M, Lesur A, Perdrizet-Chevallier C (2008) Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 110:9\u201317","journal-title":"Breast Cancer Res Treat"},{"key":"1203_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1472-6963-12-224","volume":"12","author":"KG Christensen","year":"2012","unstructured":"Christensen KG, Fenger-Gr\u00f8n M, Flarup KR, Vedsted P (2012) Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis - a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res 12:224","journal-title":"BMC Health Serv Res"},{"key":"1203_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/02813432.2016.1183692","volume":"34","author":"M Ewing","year":"2016","unstructured":"Ewing M, Naredi P, Nemes S, Zhang C, M\u00e5nsson J (2016) Increased consultation frequency in primary care, a risk marker for cancer: a case\u2013control study. Scand J Prim Health Care 34:204\u2013211","journal-title":"Scand J Prim Health Care"},{"key":"1203_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1753-6405.2009.00357.x","volume":"33","author":"A Vitry","year":"2009","unstructured":"Vitry A, Wong SA, Roughead EE, Ramsay E, Barratt J (2009) Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health 33:126\u2013130","journal-title":"Aust N Z J Public Health"},{"key":"1203_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jclinepi.2010.02.015","volume":"64","author":"CY Lu","year":"2011","unstructured":"Lu CY, Barratt J, Vitry A, Roughead E (2011) Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol 64:223\u2013228","journal-title":"J Clin Epidemiol"},{"key":"1203_CR66","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C et al (2015) The expanding role of primary care in cancer control. Lancet Oncol 16:1231\u20131272","journal-title":"Lancet Oncol"},{"key":"1203_CR67","doi-asserted-by":"publisher","DOI":"10.5694\/mja18.00199","author":"P Cormie","year":"2018","unstructured":"Cormie P, Atkinson M, Bucci L, Cust A, Eakin E et al (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust. \n                    https:\/\/doi.org\/10.5694\/mja18.00199","journal-title":"Med J Aust"},{"key":"1203_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00198-010-1225-2","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Yogendran MS (2011) Validation of a case definition for osteoporosis disease surveillance. Osteoporos Int 22:37\u201346","journal-title":"Osteoporos Int"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-019-01203-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01203-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:23:53Z","timestamp":1593905033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-019-01203-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1007\/s10552-019-01203-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}